| Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates YF Kang, C Sun, Z Zhuang, RY Yuan, Q Zheng, JP Li, PP Zhou, XC Chen, ... ACS nano 15 (2), 2738-2752, 2021 | 175 | 2021 |
| Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma M Xu, Y Yao, H Chen, S Zhang, SM Cao, Z Zhang, B Luo, Z Liu, Z Li, ... Nature genetics 51 (7), 1131-1136, 2019 | 167 | 2019 |
| Vasculogenic mimicry formation in EBV-associated epithelial malignancies T Xiang, YX Lin, W Ma, HJ Zhang, KM Chen, GP He, X Zhang, M Xu, ... Nature communications 9 (1), 5009, 2018 | 142 | 2018 |
| Structural basis for the neutralization and genotype specificity of hepatitis E virus X Tang, C Yang, Y Gu, C Song, X Zhang, Y Wang, J Zhang, CL Hew, S Li, ... Proceedings of the National Academy of Sciences 108 (25), 10266-10271, 2011 | 135 | 2011 |
| Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin® X Zhang, M Wei, H Pan, Z Lin, K Wang, Z Weng, Y Zhu, L Xin, J Zhang, ... Vaccine 32 (32), 4039-4050, 2014 | 88 | 2014 |
| Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody Y Gu, X Tang, X Zhang, C Song, M Zheng, K Wang, J Zhang, MH Ng, ... Cell research 25 (5), 604-620, 2015 | 86 | 2015 |
| Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes M Wei, X Zhang, H Yu, ZM Tang, K Wang, Z Li, Z Zheng, S Li, J Zhang, ... Vaccine 32 (24), 2859-2865, 2014 | 54 | 2014 |
| Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins X Zhang, L Xin, S Li, M Fang, J Zhang, N Xia, Q Zhao Human vaccines & immunotherapeutics 11 (5), 1277-1292, 2015 | 43 | 2015 |
| Immunization with Fc-based recombinant Epstein–Barr virus gp350 elicits potent neutralizing humoral immune response in a BALB/c mice model B Zhao, X Zhang, C Krummenacher, S Song, L Gao, H Zhang, M Xu, ... Frontiers in immunology 9, 932, 2018 | 34 | 2018 |
| Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma W Ma, L Feng, S Zhang, H Zhang, X Zhang, X Qi, Y Zhang, Q Feng, ... Cancer science 109 (5), 1710-1722, 2018 | 31 | 2018 |
| Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation HJ Zhang, J Tian, XK Qi, T Xiang, GP He, H Zhang, X Yu, X Zhang, ... PLoS pathogens 14 (7), e1007208, 2018 | 29 | 2018 |
| A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus QY Zhu, S Shan, J Yu, SY Peng, C Sun, Y Zuo, LY Zhong, SM Yan, ... Nature Communications 12 (1), 6624, 2021 | 27 | 2021 |
| CryoEM structure of the tegumented capsid of Epstein-Barr virus Z Li, X Zhang, L Dong, J Pang, M Xu, Q Zhong, MS Zeng, X Yu Cell research 30 (10), 873-884, 2020 | 26 | 2020 |
| Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment Y Zhang, M Li, F Yang, Y Li, Z Zheng, X Zhang, Q Lin, Y Wang, S Li, N Xia, ... Human Vaccines & Immunotherapeutics 11 (5), 1129-1139, 2015 | 25 | 2015 |
| Urgency and necessity of Epstein-Barr virus prophylactic vaccines L Zhong, C Krummenacher, W Zhang, J Hong, Q Feng, Y Chen, Q Zhao, ... npj Vaccines 7 (1), 159, 2022 | 22 | 2022 |
| Immunization with a self-assembled nanoparticle vaccine elicits potent neutralizing antibody responses against EBV infection YF Kang, X Zhang, XH Yu, Q Zheng, Z Liu, JP Li, C Sun, XW Kong, ... Nano Letters 21 (6), 2476-2486, 2021 | 22 | 2021 |
| A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection X Zhang, B Zhao, M Ding, S Song, Y Kang, Y Yu, M Xu, T Xiang, L Gao, ... Theranostics 10 (13), 5704, 2020 | 22 | 2020 |
| Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts C Yang, H Pan, M Wei, X Zhang, N Wang, Y Gu, H Du, J Zhang, S Li, ... Protein Science 22 (3), 314-326, 2013 | 22 | 2013 |
| Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion X Zhang, J Hong, L Zhong, Q Wu, S Zhang, Q Zhu, H Chen, D Wei, R Li, ... Proceedings of the National Academy of Sciences 119 (32), e2202371119, 2022 | 20 | 2022 |
| Functional assessment and structural basis of antibody binding to human papillomavirus capsid X Zhang, S Li, Y Modis, Z Li, J Zhang, N Xia, Q Zhao Reviews in Medical Virology 26 (2), 115-128, 2016 | 20 | 2016 |
